Posterior tibial nerve stimulation as a neuromodulation therapy in treatment of neurogenic overactive bladder in multiple sclerosis: A prospective randomized controlled study.

[1]  Deyong Yang,et al.  Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines , 2022, Parkinson's disease.

[2]  Baoyi Zhu,et al.  Prolonged Inhibitory Effects of Repeated Tibial Nerve Stimulation on the Micturition Reflex in Decorticated Rats. , 2022, Neuromodulation : journal of the International Neuromodulation Society.

[3]  K. Kim,et al.  Pelvic floor muscle exercise and training for coping with urinary incontinence , 2021, Journal of exercise rehabilitation.

[4]  H. Hussein,et al.  Bladder and urodynamic changes in multiple sclerosis , 2020, The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.

[5]  R. Dunn,et al.  A prospective observational cohort study of posterior tibial nerve stimulation in patients with multiple sclerosis: design and methods , 2020, BMC Urology.

[6]  Masaaki Ito,et al.  Spatial distribution of smooth muscle tissue in the male pelvic floor with special reference to the lateral extent of the rectourethralis muscle: Application to prostatectomy and proctectomy , 2018, Clinical anatomy.

[7]  J. Pereira,et al.  Electrostimulation of the posterior tibial nerve in individuals with overactive bladder: a literature review , 2018, Journal of physical therapy science.

[8]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[9]  Xia Zhang,et al.  Multiple sclerosis: Pathology, diagnosis and treatments , 2017, Experimental and therapeutic medicine.

[10]  M. Çetiner,et al.  Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12‐months results , 2017, Neurourology and urodynamics.

[11]  E. Chartier-Kastler,et al.  Management of neurogenic bladder in patients with multiple sclerosis , 2016, Nature Reviews Urology.

[12]  J. Pannek,et al.  Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. , 2016, European urology.

[13]  M. Malkoç,et al.  Does pelvic floor muscle training abolish symptoms of urinary incontinence? A randomized controlled trial , 2015, Clinical rehabilitation.

[14]  C. Gobbi,et al.  Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study. , 2014, The Journal of urology.

[15]  K. Peters,et al.  Neuromodulation for overactive bladder , 2013, Nature Reviews Urology.

[16]  I. Wiklund,et al.  Is home‐based pelvic floor muscle training effective in treatment of urinary incontinence after birth in primiparous women? A randomized controlled trial , 2013, Acta obstetricia et gynecologica Scandinavica.

[17]  J. Rose,et al.  Advances in the management of neurogenic detrusor overactivity in multiple sclerosis. , 2013, International journal of MS care.

[18]  M. Hung,et al.  Development and validation of the Chinese Overactive Bladder Symptom Score for assessing overactive bladder syndrome in a RESORT study. , 2013, Journal of the Formosan Medical Association = Taiwan yi zhi.

[19]  C. Gobbi,et al.  Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial , 2011, Multiple sclerosis.

[20]  L. Cardozo,et al.  Validity and reliability of the patient’s perception of intensity of urgency scale in overactive bladder , 2011, BJU international.

[21]  K. Peters,et al.  Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. , 2010, The Journal of urology.

[22]  H. Ozden,et al.  The clinical and urodynamic results of a 3‐month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis‐related neurogenic bladder dysfunction , 2009, Neurourology and urodynamics.

[23]  H. Butzkueven,et al.  Measurement of disability in multiple sclerosis , 2008 .

[24]  M. Yucel,et al.  Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study. , 2008, Urology.

[25]  K. Williams,et al.  Bladder training for urinary incontinence in adults. , 2004, The Cochrane database of systematic reviews.

[26]  G. Scivoletto,et al.  Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. , 1999, Archives of physical medicine and rehabilitation.

[27]  E. Frohman,et al.  Multiple sclerosis and the urologist. , 1999, The Journal of urology.

[28]  H. Poppel,et al.  Pelvic floor rehabilitation in multiple sclerosis. , 1999, Acta neurologica Belgica.

[29]  J. Schnelle,et al.  Does Oxybutynin Add to the Effectiveness of Prompted Voiding For Urinary Incontinence Among Nursing Home Residents? A Placebo‐Controlled Trial , 1995, Journal of the American Geriatrics Society.

[30]  C. Fowler,et al.  Intravesical capsaicin for treatment of detrusor hyperreflexia. , 1994, Journal of Neurology Neurosurgery & Psychiatry.

[31]  M. Basheer,et al.  Effect of Repetitive Transcranial Magnetic Stimulation on Motor Functions in Multiple Sclerosis Patients: A Randomized Controlled Trial , 2019, Indian Journal of Public Health Research & Development.

[32]  T. Alsaadi,et al.  Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines. , 2019, Multiple sclerosis and related disorders.

[33]  M. Brin,et al.  Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. , 2005, The Journal of urology.